The Medicaid Drug Utilization Review (DUR) Program was created by the Omnibus Budget Reconciliation Act (OBRA) of 1990. The main emphasis of the program is to promote patient safety by an increased review and awareness of outpatient prescribed drugs. States were encouraged by enhanced federal funding to design and install point-of-sale electronic claims management systems that interface with their Medicaid Management Information Systems (MMIS) operations. The annual report requirement provides an excellent measurement tool to assess how well patient safety, provider prescribing habits and dollars saved by avoidance of problems such as drug-drug interactions, drug-disease interactions, therapeutic duplication, and over-prescribing by providers.

Downloads
There are no Downloads
Related Links Inside CMS
There are no Related Links Inside CMS
Related Links Outside CMS
There are no Related Links Outside CMS